Chapter 10: Infusion Medication Safety, Methods, and Routes

Chapter 10: Infusion Medication Safety, Methods, and Routes

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

Multiple Choice

Identify the choice that best completes the statement or answers the question.

 

____     1.   An oncologist orders an antineoplastic agent to be delivered to a client via the intraperitoneal route. Intraperitoneal delivery of antineoplastic therapy delivers the drug directly into:

a.	an artery.
b.	a cavity.
c.	a vein.
d.	a ventricle.

 

 

____     2.   A trauma physician orders an intraosseous (IO) infusion for an 8-year-old child. A nurse uses the EZ-IO to insert the IO infusion knowing that intraosseous infusions are used for:

a.	home antibiotic therapy.
b.	long-term nutritional support in children.
c.	delivery of fluids, electrolytes, and medications to children and adults when venous access is not attainable.
d.	delivery of fluids and medications only to children younger than 6 years old.

 

 

____     3.   A committee is asked to investigate ways to reduce needlestick injuries in a hospital. Which technology best assists in the reduction of needlestick injuries?

a.	Luer locks
b.	Elastomeric pumps
c.	Needleless systems
d.	Three-way stopcocks

 

 

____     4.   A nurse is about to administer an I.V. push medication through a locking device. Which action should the nurse take with the nondominant hand while piercing the resealable lock port with the dominant hand?

a.	Hold a watch that has a second hand.
b.	Stabilize the port of the locking device.
c.	Wipe the insertion site with an alcohol swab for 15 seconds.
d.	Apply pressure over the catheter insertion site.

 

 

____     5.   A physician’s assistant orders two medications for a client and instructs a nurse to administer the medications together. The nurse questions the order because incompatibilities can occur when two drugs are compounded. These incompatibilities may include:

a.	intermittent, physical, and biotransformation incompatibilities.
b.	drug interaction, synergism, and tolerance.
c.	physical, chemical, and therapeutic incompatibilities.
d.	anaphylaxis, tolerance, and drug interactions.

 

Answer Section

 

MULTIPLE CHOICE

 

1. ANS:  B

Intraperitoneal drug administration deposits drugs directly into body cavities, such as the bladder, peritoneum, pleura, and pericardium. Regional routes include intra-arterial delivery of drugs into an artery and intraventricular routes into the ventricles.

Reference: Phillips, L. D., & Gorski, L. (2014). In Manual of I.V. therapeutics: Evidence-based infusion therapy (6th ed.). Philadelphia, PA: F.A. Davis.

 

PTS:   1                    KEY:  Cognitive Level: Application

 

2. ANS:  C

The route is limited to 24 hours.

 

PTS:   1                    KEY:  Cognitive Level: Application

 

3. ANS:  C

The needleless system has taken the place of 80% of needles used in I.V. therapy for piggyback, accessing ports, and accessing locking devices. Elastomeric pumps primarily deliver medications in the home-care environment. Luer locks help maintain integrity of connectors, and three-way stopcocks provide access options into the I.V. system. Stopcocks are add-on devices and should be used with caution because of the risk for contamination.

 

PTS:   1                    KEY:  Cognitive Level: Application

 

4. ANS:  B

The nurse should use the nondominant hand to stabilize the port of the locking device, which prevents the catheter from moving in the vein and possibly traumatizing the vein wall.

 

PTS:   1                    KEY:  Cognitive Level: Application

 

5. ANS:  C

Incompatibilities occur when two or more substances react or interact to change the normal activity of one or more components. Physical incompatibility, also called pharmaceutical incompatibility, occurs when one drug is mixed with other drugs or solutions to produce an unsafe product. Chemical incompatibility is defined as the reaction of a drug with other drugs or solutions that results in an alteration of the integrity and potency of the active ingredient. Therapeutic incompatibility is an undesirable effect that occurs within a client, and as a result, there is either a decrease or an increase in therapeutic response.

 

PTS:   1                    KEY:  Cognitive Level: Application